3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
2
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Carcinoma, Non-Small-Cell Lung
10
Rectal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Stomach Neoplasms
4
Thyroid Neoplasms
2
Oropharyngeal Neoplasms
2
NSCLC
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thymic epithelial tumor
1
Spinal Metastasis
1
Sarcoma
1
Resectable Non-small Cell Lung Cancer
1
Recurrence
1
Prostatic Neoplasms
1
Pilonidal Sinus
1
Pathologic Complete Response
1
Pancoast Syndrome
1
Pain, Postoperative
1
Pain
1
Ovarian Neoplasms
1
Mouth Neoplasms
1
Microsatellite Instability
1
Interventions
Carboplatin
3
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
selinexor
1
ponatinib
1
poly ICLC
1
pemigatinib
1
neratinib
1
donafenib
1
cobimetinib
1
ceritinib
1
cemiplimab
1
brigatinib
1
abemaciclib
1
Thymopentin
1
Taxes
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Radiation
1
Pluvicto
1
Platinum Compounds
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Nivolumab
1
Neck Dissection
1
NF protocol
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Carcinoma
×
Surgical Procedures, Operative
×
Clear all
NCT05144100
2021-12-03
SCOPE
Tata Memorial Centre
Phase 2/3
Not yet recruiting
498 enrolled